Eventide Asset Management - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 69 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q1 2020$2,033,000
-45.2%
270,0000.0%0.07%
-37.1%
Q4 2019$3,713,000
+15.7%
270,0000.0%0.10%
-0.9%
Q3 2019$3,208,000
-15.1%
270,0000.0%0.11%
-7.8%
Q2 2019$3,777,000
-21.8%
270,0000.0%0.12%
-30.7%
Q1 2019$4,828,000
+13.7%
270,0000.0%0.17%
-11.7%
Q4 2018$4,247,000270,0000.19%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
CHI Advisors LLC 6,449,856$8,514,0002.83%
RA Capital Management 9,694,789$12,797,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$9,173,0000.19%
HARBOR CAPITAL ADVISORS, INC. 275,870$364,0000.13%
Artal Group S.A. 1,803,858$2,381,0000.06%
GSA CAPITAL PARTNERS LLP 338,756$447,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 1,335,174$1,762,0000.05%
PVG ASSET MANAGEMENT CORP 10,000$13,200,0000.05%
Anson Funds Management LP 348,266$460,0000.04%
Eversept Partners, LP 419,581$553,8470.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders